Apr 13, 2023 · Boston Scientific's estimated fair value is US$41.64 based on 2 Stage Free Cash Flow to Equity. Boston Scientific's US$51.11 share price signals that it might be 23% overvalued. The US$53.11 ... Mar 3, 2021 · MARLBOROUGH, Mass., March 3, 2021 /PRNewswire/ -- Boston Scientific (NYSE: BSX) today announced that it has entered into a definitive agreement with an affiliate of Baring Private Equity Asia (BPEA) to acquire the global surgical business of Lumenis LTD., a privately-held company that develops and commercializes energy-based medical solutions, for an upfront cash payment of $1.07 billion ... BSX | July 27, 2023. MARLBOROUGH, Mass., July 27, 2023 /PRNewswire/ -- Boston Scientific Corporation (NYSE: BSX) generated net sales of $3.599 billion during the second quarter of 2023, growing 11.0 percent on a reported basis, 12.0 percent on an operational 1 basis and 11.6 percent on an organic 2 basis, all compared to the prior year period.Boston Scientific Corp. BSX (U.S.: NYSE) Overview News Boston Scientific Corp. No significant news for in the past two years. Key Stock Data P/E Ratio (TTM) 90.55 ( 09/08/23) EPS (TTM)...Sep 15, 2023 · Raleigh Capital Management Inc. bought a new position in shares of Boston Scientific Co. (NYSE:BSX - Free Report) in the 1st quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm bought 2,704 shares of the medical equipment provider's stock, valued a Boston Scientific (NYSE:BSX) announced today that it completed the nearly $1.1 billion acquisition of the global surgical business of Lumenis. Marlborough, Massachusetts–based Boston Scientific ...MARLBOROUGH, Mass., May 9, 2019 /PRNewswire/ -- Boston Scientific (NYSE: BSX) today announced that it has entered into a definitive agreement to acquire Vertiflex, Inc., a privately-held company which has developed and commercialized the Superion ® Indirect Decompression System, a minimally-invasive device used to improve physical function and reduce pain in patients with lumbar spinal ...Aug 15, 2022 · MARLBOROUGH, Mass., Aug. 15, 2022 /PRNewswire/ -- Boston Scientific Corporation (NYSE: BSX) today announced the acquisition of Obsidio, Inc., a privately-held company that has developed the Gel ... MARLBOROUGH, Mass., April 23, 2019 /PRNewswire/ -- Boston Scientific Corporation (NYSE: BSX) today announced it has received U.S. Food and Drug Administration (FDA) approval for the LOTUS Edge ...MARLBOROUGH, Mass., Aug. 2, 2021 /PRNewswire/ -- Boston Scientific (NYSE: BSX) announced that the U.S. Centers for Medicare & Medicaid Services (CMS) granted a New Technology Add-on Payment (NTAP) for single-use duodenoscopes, applicable to the EXALT™ Model D Single-Use Duodenoscope, as part of its Fiscal Year 2022 Hospital Inpatient Prospective Payment System.Sep 1, 2021 · Boston Scientific (NYSE:BSX) announced today that it completed the nearly $1.1 billion acquisition of the global surgical business of Lumenis.. Marlborough, Massachusetts–based Boston Scientific ... Boston Scientific Co. has a 52 week low of $37.74 and a 52 week high of $54.74. Boston Scientific ( NYSE:BSX – Get Free Report) last released its earnings results on Thursday, July 27th. The ...Boston Scientific Price Performance. Shares of NYSE:BSX opened at $53.86 on Thursday. The company has a quick ratio of 0.80, a current ratio of 1.29 and a debt-to-equity ratio of 0.46.Sep 6, 2023 · MARLBOROUGH, Mass., Sept. 6, 2023 /PRNewswire/ -- Boston Scientific Corporation (NYSE: BSX) today announced it has received U.S. Food and Drug Administration approval for the latest-generation ... Hamilton, Bermuda — 10 February 2023 — The Bermuda Stock Exchange (BSX), a wholly owned subsidiary of Miami International Holdings, Inc., today reported its 2022 year-end results, with international debt listings and new listings of. Read more The BSX Rings the Bell for Financial Literacy and Announces New Investor Education InitiativeBSX | July 27, 2023. MARLBOROUGH, Mass., July 27, 2023 /PRNewswire/ -- Boston Scientific Corporation (NYSE: BSX) generated net sales of $3.599 billion during the second quarter of 2023, growing 11.0 percent on a reported basis, 12.0 percent on an operational 1 basis and 11.6 percent on an organic 2 basis, all compared to the prior year period. cast of now you see mepdf candy Sep 15, 2023 · Nexus Investment Management ULC raised its holdings in shares of Boston Scientific Co. (NYSE:BSX – Free Report) by 0.8% in the 2nd quarter, according to its most recent filing with the ... Boston Scientific Corporation (NYSE:BSX) shares, rose in value on Friday, 07/28/23, with the stock price down by -1.80% to the previous day’s close as strong demand from buyers drove the stock to $51.69. Actively observing the price movement in the last trading, the stock closed the session at $52.64, falling within a range of $51.16 and $53.11.Bermuda Stock Exchange - BSX: The stock exchange headquartered in Hamilton, Bermuda.Boston Scientific Corporation (NYSE:BSX)’s traded shares stood at 8.08 million during the last session, with the company’s beta value hitting 0.78. At the close of trading, the stock’s price was $53.94, to imply a decrease of -0.61% or -$0.33 in intraday trading. The BSX share’s 52-week highMARLBOROUGH, Mass., Aug. 15, 2022 /PRNewswire/ -- Boston Scientific Corporation (NYSE: BSX) today announced the acquisition of Obsidio, Inc., a privately-held company that has developed the Gel ...06 Oct, 2021, 07:00 ET. MARLBOROUGH, Mass., Oct. 6, 2021 /PRNewswire/ -- Boston Scientific Corporation (NYSE: BSX) today announced that it has entered into a definitive agreement to acquire Baylis ...In certain circumstances, securities with respect to which the relevant exchange has commenced delisting proceedings may continue to be traded pending appeal of that determination. To view a list of securities that are subject to delisting, including those that continue to be traded pending appeal, please click here.Bleakley Financial Group LLC raised its holdings in Boston Scientific Co. (NYSE:BSX – Free Report) by 3.0% in the first quarter, according to the company in its most recent Form 13F filing with ...Boston Scientific Co. has a 1-year low of $37.74 and a 1-year high of $54.99. Boston Scientific ( NYSE:BSX - Get Free Report) last posted its quarterly earnings data on Thursday, July 27th. The medical equipment provider reported $0.53 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.49 by $0.04.The trading price of Boston Scientific Corporation (NYSE:BSX) floating lower at last check on Tuesday, September 05, closing at $53.44, -0.34% lower than its previous close. Traders who pay close attention to intraday price movement should know that it has been fluctuating between $53.34 and $54.26. The company’s P/E ratio in the trailing 12 ...NYSE: BSX Show Full Chart Market Closed Sep 7, 2023 7:00 PM EDT | Currency in USD Overview Key Ratios Trading Information Last Close 53.89 Sector Healthcare Industry Medical Devices Investment...(NYSE: BSX) Boston Scientific currently has 1,464,223,263 outstanding shares. With Boston Scientific stock trading at $53.62 per share, the total value of Boston Scientific stock (market capitalization) is $78.51B. winchester savings bank Symbol. Price. %Change. BSX. 53.50. -0.87%. Webull offers kinds of Boston Scientific Corporation stock information, including NYSE:BSX real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, BSX stock news, and many more online research tools to help you make informed decisions. Jan 25, 2006 Boston Scientific and Guidant Announce Signing of Merger Agreement Valued at $27 Billion. Natick, MA and Indianapolis, IN - Boston Scientific Corporation (NYSE: BSX) and Guidant Corporation (NYSE: GDT) today announced that the Board of Directors of Guidant has unanimously approved and entered into the merger agreement provided to Guidant by Boston Scientific on January 17, 2006. Boston Scientific Co. has a 52 week low of $37.74 and a 52 week high of $54.74. Boston Scientific ( NYSE:BSX – Get Free Report) last released its earnings results on Thursday, July 27th. The ...Boston Scientific Co. has a 1-year low of $37.74 and a 1-year high of $54.99. Boston Scientific ( NYSE:BSX - Get Free Report) last posted its quarterly earnings data on Thursday, July 27th. The medical equipment provider reported $0.53 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.49 by $0.04.Apr 30, 2022 · Bermuda Stock Exchange - BSX: The stock exchange headquartered in Hamilton, Bermuda. Aug 2, 2021 · MARLBOROUGH, Mass., Aug. 2, 2021 / PRNewswire / -- Boston Scientific (NYSE: BSX) announced that the U.S. Centers for Medicare & Medicaid Services (CMS) granted a New Technology Add-on Payment (NTAP) for single-use duodenoscopes, applicable to the EXALT™ Model D Single-Use Duodenoscope, as part of its Fiscal Year 2022 Hospital Inpatient ... Jul 27, 2023 · Boston Scientific Corporation (NYSE:NYSE:BSX) Q2 2023 Earnings Conference Call July 27, 2023 7:30 AM ETCompany ParticipantsLauren Tengler - VP, IRMike Mahoney - Chairman & CEODan... MARLBOROUGH, Mass., March 3, 2021 /PRNewswire/ -- Boston Scientific (NYSE: BSX) today announced that it has entered into a definitive agreement with an affiliate of Baring Private Equity Asia (BPEA) to acquire the global surgical business of Lumenis LTD., a privately-held company that develops and commercializes energy-based medical solutions, for an upfront cash payment of $1.07 billion ...06 Oct, 2021, 07:00 ET. MARLBOROUGH, Mass., Oct. 6, 2021 /PRNewswire/ -- Boston Scientific Corporation (NYSE: BSX) today announced that it has entered into a definitive agreement to acquire Baylis ... miller ale house T2 Biosystems, Inc. Common Stock. $0.56 +0.1067 +23.54%. Investors may trade in the Pre-Market (4:00-9:30 a.m. ET) and the After Hours Market (4:00-8:00 p.m. ET). Participation from Market Makers ...Boston Scientific Corporation (NYSE:BSX) shares, rose in value on Thursday, 09/07/23, with the stock price up by 0.06% to the previous day’s close as strong demand from buyers drove the stock to $53.89. Actively observing the price movement in the last trading, the stock closed the session at $53.86, falling within a range of $53.78 and $54.755.View Boston Scientific Corporation BSX investment & stock information. Get the latest Boston Scientific Corporation BSX detailed stock quotes, stock data, Real-Time ECN, charts, stats and more.Feb 1, 2023 · Boston Scientific Corporation (NYSE:NYSE:BSX) Q4 2022 Results Conference Call February 1, 2023 8:00 AM ETCompany ParticipantsLauren Tengler - Vice President, Investor RelationsMike Mahoney... Aug 6, 2023 · Bellwether Advisors LLC increased its holdings in shares of Boston Scientific Co. (NYSE:BSX - Free Report) by 24.1% in the first quarter, according to its most recent filing with the SEC. The fund owned 48,337 shares of the medical equipment provider's stock after acquiring an additional 9,376 shar Jul 28, 2023 · In May Boston Scientific Corporation (NYSE:BSX) cancelled its plan to buy a majority stake in the publicly listed Korean medical device maker M.I.Tech for $230 million amid regulatory concerns. 8. MARLBOROUGH, Mass., June 11, 2019 /PRNewswire/ -- Boston Scientific Corporation (NYSE: BSX) today announced the close of its acquisition of Vertiflex, Inc., a privately-held company that developed and commercialized the Superion ® Indirect Decompression System, a minimally-invasive device used to improve physical function and reduce pain in patients with lumbar spinal stenosis (LSS) – the ...MARLBOROUGH, Mass., Sept. 5, 2023 /PRNewswire/ -- Boston Scientific Corporation (NYSE: BSX) will host a meeting with the investor community to review its financial goals and long-term growth ...Sep 12, 2023 · Boston Scientific Corporation (NYSE:BSX) entered into a definitive merger agreement to acquire Apollo Endosurgery, Inc. (NasdaqGM:APEN) for approximately $440 million. Nov 30 Boston Scientific Corporation Announces the First Results from the ACURATE neo2 Post Market Clinical Follow-up (PMCF) Study MARLBOROUGH, Mass., June 15, 2022 /PRNewswire/ -- Boston Scientific Corporation (NYSE: BSX) today announced that it has entered into a definitive agreement with Synergy Innovation Co., Ltd, to ...(NYSE: BSX) Boston Scientific currently has 1,464,223,263 outstanding shares. With Boston Scientific stock trading at $53.62 per share, the total value of Boston Scientific stock (market capitalization) is $78.51B.MARLBOROUGH, Mass., Aug. 2, 2021 /PRNewswire/ -- Boston Scientific (NYSE: BSX) announced that the U.S. Centers for Medicare & Medicaid Services (CMS) granted a New Technology Add-on Payment (NTAP) for single-use duodenoscopes, applicable to the EXALT™ Model D Single-Use Duodenoscope, as part of its Fiscal Year 2022 Hospital Inpatient Prospective Payment System.Aug 25, 2023 · Boston Scientific Corporation (NYSE:BSX) trade information. Upright in the green during last session for gaining 0.16%, in the last five days BSX remained trading in the red while hitting it’s week-highest on Thursday, 08/24/23 when the stock touched $50.43 price level, adding 1.41% to its value on the day. mms message Apr 9, 2021 · NYSE:BSX Debt to Equity History April 9th 2021 How Strong Is Boston Scientific's Balance Sheet? The latest balance sheet data shows that Boston Scientific had liabilities of US$3.68b due within a ... How much insider selling is happening at Boston Scientific? Insiders have sold a total of 1,620,273 Boston Scientific shares in the last 24 months for a total of $72,328,828.34 sold.MARLBOROUGH, Mass., Dec. 11, 2022 /PRNewswire/ -- Boston Scientific Corporation (NYSE: BSX) and Acotec Scientific Holdings Limited ("Acotec" and 6669.HK) announced today that Boston Scientific will make a partial offer to acquire a majority stake, up to a maximum of 65%, of shares of Acotec, a Chinese medical technology company that offers solutions designed for a variety of interventional ...Feb 2, 2023 · February 2, 2023 at 3:58 PM · 21 min read. Boston Scientific Corporation (NYSE: BSX) Q4 2022 Earnings Call Transcript February 1, 2023. Operator: Good morning, and welcome to the Boston ... BSX Q1'23 Performance Report. Through these activities, Boston Scientific has recorded Q1 revenues of $3.39bn- a 12.00% YoY increase-alongside a net income of $314.00mn- a 182.88% increase- and a ... bruster's NYSE BSX opened at $53.62 on Friday. Boston Scientific Co. has a 52 week low of $37.74 and a 52 week high of $54.99. The company has a current ratio of 1.29, a quick ratio of 0.80 and a debt-to ...Boston Scientific Co. (NYSE:BSX - Get Free Report) Director Charles J. Dockendorff sold 17,079 shares of Boston Scientific stock in a transaction that occurred on Friday, August 18th. The shares were sold at an average price of $50.74, for a total transaction of $866,588.46. Following the sale, the director now owns 3,946 shares of the company's stock, valued at $200,220.04. The transaction ...Jul 27, 2023 · Boston Scientific Corporation (NYSE:NYSE:BSX) Q2 2023 Earnings Conference Call July 27, 2023 7:30 AM ETCompany ParticipantsLauren Tengler - VP, IRMike Mahoney - Chairman & CEODan... Apr 23, 2019 · MARLBOROUGH, Mass., April 23, 2019 /PRNewswire/ -- Boston Scientific Corporation (NYSE: BSX) today announced it has received U.S. Food and Drug Administration (FDA) approval for the LOTUS Edge ... Boston Scientific (NYSE:BSX) announced today that it completed the nearly $1.1 billion acquisition of the global surgical business of Lumenis. Marlborough, Massachusetts–based Boston Scientific ...Aug 15, 2022 · MARLBOROUGH, Mass., Aug. 15, 2022 /PRNewswire/ -- Boston Scientific Corporation (NYSE: BSX) today announced the acquisition of Obsidio, Inc., a privately-held company that has developed the Gel ... Jun 15, 2022 · MARLBOROUGH, Mass., June 15, 2022 /PRNewswire/ -- Boston Scientific Corporation (NYSE: BSX) today announced that it has entered into a definitive agreement with Synergy Innovation Co., Ltd, to purchase its majority stake (approximately 64 percent) of M.I.Tech Co., Ltd, ("M.I.Tech") a publicly traded Korean manufacturer and distributor of medical devices for endoscopic and urologic procedures. Boston Scientific Corporation (NYSE:BSX) shares, rose in value on Thursday, 09/07/23, with the stock price up by 0.06% to the previous day’s close as strong demand from buyers drove the stock to $53.89. Actively observing the price movement in the last trading, the stock closed the session at $53.86, falling within a range of $53.78 and $54.755.May 1, 2020 · Boston Scientific (NYSE: BSX) and EndoChoice Holdings, Inc. (NYSE: GI) today announced the companies have entered into a definitive agreement under which Boston Scientific has agreed to acquire EndoChoice. Upon completion of. 2016-09-27: EX-99.1: BOSTON SCIENTIFIC TO ACQUIRE ENDOCHOICE Acquisition Will Expand Endoscopy Gastroenterology Portfolio destiny trials report Sep 8, 2023 · Boston Scientific Corporation (NYSE:BSX) shares, rose in value on Thursday, 09/07/23, with the stock price up by 0.06% to the previous day’s close as strong demand from buyers drove the stock to $53.89. Actively observing the price movement in the last trading, the stock closed the session at $53.86, falling within a range of $53.78 and $54.755. Sep 11, 2023 · The public float for BSX is 1.46B and currently, short sellers hold a 0.60% of that float. On September 11, 2023, BSX’s average trading volume was 7.14M shares. BSX) stock’s latest price update. Boston Scientific Corporation (NYSE: BSX) has seen a decline in its stock price by -0.04 in relation to its previous close of 53.89. The public float for BSX is 1.46B and currently, short sellers hold a 0.60% of that float. On September 11, 2023, BSX’s average trading volume was 7.14M shares. BSX) stock’s latest price update. Boston Scientific Corporation (NYSE: BSX) has seen a decline in its stock price by -0.04 in relation to its previous close of 53.89.For example, the Boston Scientific Corporation ( NYSE:BSX) share price is 51% higher than it was five years ago, which is more than the market average. It's also good to see a healthy gain of 32% ... creature girls a hands on field journal in another world 15 Wall Street analysts have issued 12-month price targets for Boston Scientific's stock. Their BSX share price forecasts range from $50.00 to $64.00. On average, they expect the company's share price to reach $58.50 in the next twelve months. This suggests a possible upside of 8.6% from the stock's current price.Nov 30, 2022 · The Boston-area medical device maker (NYSE: BSX) is set to buy Apollo Endosurgery Inc. (Nasdaq: APEN) at $10 a share, about a 60% premium over where it had been trading over the past week. tiktok follower generator MARLBOROUGH, Mass., Feb. 1, 2023 /PRNewswire/ -- Boston Scientific Corporation (NYSE: BSX) generated net sales of $3.242 billion during the fourth quarter of 2022, growing 3.7 percent on a reported basis, 8.7 percent on an operational 1 basis and 7.1 percent on an organic 2 basis, all compared to the prior year period.According to the issued ratings of 16 analysts in the last year, the consensus rating for Boston Scientific stock is Buy based on the current 1 hold rating, 14 buy ratings and 1 strong buy rating for BSX. The average twelve-month price prediction for Boston Scientific is $58.50 with a high price target of $64.00 and a low price target of $50.00.1 day ago · We believe that Boston Scientific stock (NYSE: BSX) is a better pick over Altria stock (NYSE: MO), given its better prospects. Although these companies are from different sectors, we compare them ... Bellwether Advisors LLC increased its holdings in shares of Boston Scientific Co. (NYSE:BSX - Free Report) by 24.1% in the first quarter, according to its most recent filing with the SEC. The fund owned 48,337 shares of the medical equipment provider's stock after acquiring an additional 9,376 sharSep 14, 2023 · Livforsakringsbolaget Skandia Omsesidigt lessened its position in shares of Boston Scientific Co. (NYSE:BSX – Free Report) by 9.1% in the second quarter, according to the company in its most ... Sep 14, 2023 · Coastline Trust Co acquired a new stake in Boston Scientific Co. ( NYSE:BSX - Free Report) during the 1st quarter, according to the company in its most recent filing with the SEC. The institutional investor acquired 5,250 shares of the medical equipment provider's stock, valued at approximately $263,000. Other large investors have also recently ... Nexus Investment Management ULC raised its holdings in shares of Boston Scientific Co. (NYSE:BSX – Free Report) by 0.8% in the 2nd quarter, according to its most recent filing with the ...Aug 20, 2023 · Boston Scientific Co. (NYSE:BSX - Get Free Report) Director Charles J. Dockendorff sold 17,079 shares of Boston Scientific stock in a transaction that occurred on Friday, August 18th. The shares were sold at an average price of $50.74, for a total transaction of $866,588.46. Following the sale, the director now owns 3,946 shares of the company's stock, valued at $200,220.04. The transaction ... Boston Scientific (NYSE: BSX) and EndoChoice Holdings, Inc. (NYSE: GI) today announced the companies have entered into a definitive agreement under which Boston Scientific has agreed to acquire EndoChoice. Upon completion of. 2016-09-27: EX-99.1: BOSTON SCIENTIFIC TO ACQUIRE ENDOCHOICE Acquisition Will Expand Endoscopy Gastroenterology PortfolioSep 5, 2023 · MARLBOROUGH, Mass., Sept. 5, 2023 /PRNewswire/ -- Boston Scientific Corporation (NYSE: BSX) will host a meeting with the investor community to review its financial goals and long-term growth ... Home BSX • NYSE Boston Scientific Corporation Follow Share $53.87 After Hours: $53.92 (0.093%) +0.050 Closed: Sep 8, 5:03:29 PM GMT-4 · USD · NYSE · Disclaimer search Compare to Medtronic...Home BSX • NYSE Boston Scientific Corporation Follow Share $53.87 After Hours: $53.92 (0.093%) +0.050 Closed: Sep 8, 5:03:29 PM GMT-4 · USD · NYSE · Disclaimer search Compare to Medtronic...15 Wall Street analysts have issued 12-month price targets for Boston Scientific's stock. Their BSX share price forecasts range from $50.00 to $64.00. On average, they expect the company's share price to reach $58.50 in the next twelve months. This suggests a possible upside of 8.6% from the stock's current price. smart care login Jul 27, 2023 · Boston Scientific Corporation (NYSE:NYSE:BSX) Q2 2023 Earnings Conference Call July 27, 2023 7:30 AM ETCompany ParticipantsLauren Tengler - VP, IRMike Mahoney - Chairman & CEODan... Oct 6, 2021 · 06 Oct, 2021, 07:00 ET. MARLBOROUGH, Mass., Oct. 6, 2021 /PRNewswire/ -- Boston Scientific Corporation (NYSE: BSX) today announced that it has entered into a definitive agreement to acquire Baylis ... Jul 27, 2023 · MARLBOROUGH, Mass., July 27, 2023 /PRNewswire/ -- Boston Scientific Corporation (NYSE: BSX) generated net sales of $3.599 billion during the second quarter of 2023, growing 11.0 percent on a reported basis, 12.0 percent on an operational 1 basis and 11.6 percent on an organic 2 basis, all compared to the prior Jan 25, 2006. Boston Scientific and Guidant Announce Signing of Merger Agreement Valued at $27 Billion. Natick, MA and Indianapolis, IN - Boston Scientific Corporation (NYSE: BSX) and Guidant Corporation (NYSE: GDT) today announced that the Board of Directors of Guidant has unanimously approved and entered into the merger agreement provided to ...Real time Boston Scientific (BSX) stock price quote, stock graph, news & analysis.Boston Scientific Co. (NYSE:BSX - Get Free Report) Director Charles J. Dockendorff sold 17,079 shares of Boston Scientific stock in a transaction that occurred on Friday, August 18th. The shares were sold at an average price of $50.74, for a total transaction of $866,588.46. Following the sale, the director now owns 3,946 shares of the company's stock, valued at $200,220.04. The transaction ...Aug 6, 2023 · Bellwether Advisors LLC increased its holdings in shares of Boston Scientific Co. (NYSE:BSX - Free Report) by 24.1% in the first quarter, according to its most recent filing with the SEC. The fund owned 48,337 shares of the medical equipment provider's stock after acquiring an additional 9,376 shar Jul 29, 2023 · July 29, 2023 at 7:24 AM · 16 min read. Boston Scientific Corporation (NYSE: BSX) Q2 2023 Earnings Call Transcript July 27, 2023. Boston Scientific Corporation misses on earnings expectations ... Sep 1, 2021 · Boston Scientific (NYSE:BSX) announced today that it completed the nearly $1.1 billion acquisition of the global surgical business of Lumenis.. Marlborough, Massachusetts–based Boston Scientific ... naver papago Boston Scientific Corporation (NYSE:BSX)’s beta value is holding at 0.78, while the average true range (ATR) indicator is currently reading 0.83. Considering analysts have assigned the stock a price target range of $55.00-$68.00 as the low and high respectively, we find the trailing 12-month average consensus price target to be $60.50.Aug 8, 2023 · August 8, 2023. Technologies. In the last trading session, 8.71 million Boston Scientific Corporation (NYSE:BSX) shares changed hands as the company’s beta touched 0.78. With the company’s per share price at $50.73 changed hands at $0.01 or 0.02% during last session, the market valuation stood at $73.16B. BSX’s last price was a discount ... Boston Scientific Corporation (NYSE:NYSE:BSX) Q2 2023 Earnings Conference Call July 27, 2023 7:30 AM ETCompany ParticipantsLauren Tengler - VP, IRMike Mahoney - Chairman & CEODan...Jul 29, 2023 · Boston Scientific Corporation (NYSE:BSX) shares, rose in value on Friday, 07/28/23, with the stock price down by -1.80% to the previous day’s close as strong demand from buyers drove the stock to $51.69. Actively observing the price movement in the last trading, the stock closed the session at $52.64, falling within a range of $51.16 and $53.11. Ossiam lifted its position in shares of Boston Scientific Co. (NYSE:BSX - Free Report) by 262.8% during the 1st quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 61,441 shares of the medical equipment provider's stock after purchasing anThe Boston-area medical device maker (NYSE: BSX) is set to buy Apollo Endosurgery Inc. (Nasdaq: APEN) at $10 a share, about a 60% premium over where it had been trading over the past week. By ...MARLBOROUGH, Mass., April 23, 2019 /PRNewswire/ -- Boston Scientific Corporation (NYSE: BSX) today announced it has received U.S. Food and Drug Administration (FDA) approval for the LOTUS Edge ...BSX U.S.: NYSE Boston Scientific Corp. Watch list Open Last Updated: Sep 7, 2023 2:13 p.m. EDT Real time quote $ 54.19 0.33 0.61% Previous Close $53.86 Advanced Charting Volume: 4.29M 65 Day... Boston Scientific Stock Down 0.5 %. Shares of NYSE BSX opened at $52.92 on Friday. Boston Scientific Co. has a 12-month low of $37.74 and a 12-month high of $54.99. The company has a market ...Raleigh Capital Management Inc. bought a new position in shares of Boston Scientific Co. (NYSE:BSX - Free Report) in the 1st quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm bought 2,704 shares of the medical equipment provider's stock, valued aBoston Scientific Corporation (NYSE:NYSE:BSX) Q2 2023 Earnings Conference Call July 27, 2023 7:30 AM ETCompany ParticipantsLauren Tengler - VP, IRMike Mahoney - Chairman & CEODan...Livforsakringsbolaget Skandia Omsesidigt lessened its position in shares of Boston Scientific Co. (NYSE:BSX – Free Report) by 9.1% in the second quarter, according to the company in its most ...Aug 25, 2023 · Boston Scientific Corporation (NYSE:BSX) trade information. Upright in the green during last session for gaining 0.16%, in the last five days BSX remained trading in the red while hitting it’s week-highest on Thursday, 08/24/23 when the stock touched $50.43 price level, adding 1.41% to its value on the day. Jul 27, 2023 · Boston Scientific Corporation (NYSE:NYSE:BSX) Q2 2023 Earnings Conference Call July 27, 2023 7:30 AM ETCompany ParticipantsLauren Tengler - VP, IRMike Mahoney - Chairman & CEODan... Boston Scientific (NYSE:BSX) announced today that it agreed with Synergy Innovation to purchase its majority stake in M.I. Tech.. Marlborough, Massachusetts-based Boston Scientific will acquire a ...Aug 21, 2023 · Boston Scientific Co. has a 52 week low of $37.74 and a 52 week high of $54.74. Boston Scientific ( NYSE:BSX – Get Free Report) last released its earnings results on Thursday, July 27th. The ... fan base Sep 15, 2023 · Raleigh Capital Management Inc. bought a new position in shares of Boston Scientific Co. (NYSE:BSX - Free Report) in the 1st quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm bought 2,704 shares of the medical equipment provider's stock, valued a Boston Scientific (NYSE:BSX) announced today that it agreed with Synergy Innovation to purchase its majority stake in M.I. Tech.. Marlborough, Massachusetts-based Boston Scientific will acquire a ...Boston Scientific last posted its quarterly earnings results on July 27th, 2023. The medical equipment provider reported $0.53 earnings per share for the quarter, beating analysts' consensus estimates of $0.49 by $0.04. The company earned $3.60 billion during the quarter, compared to analyst estimates of $3.50 billion.Nisa Investment Advisors LLC boosted its position in shares of Boston Scientific Co. (NYSE:BSX - Free Report) by 3.9% in the first quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 334,482 shares of the medical equipmenBoston Scientific Corporation (NYSE:BSX) trade information. Instantly BSX has been showing red trend so far today with a performance of -0.59% on intraday trading today. The performance over the last five days has remained in the red territory. The rise to weekly highs of 54.99 on Tuesday, 09/05/23 increased the stock’s daily price by 3.64%.Boston Scientific Corp. (NYSE: BSX) Q3 2022 earnings call dated Oct. 26, 2022 Corporate Participants: Lauren Tengler -- Vice President, Investor Relations Michael F. Mahoney -- Chairman and Chief Executive Officer Daniel J. Brennan -- Executive Vice President and Chief Financial Officer Ken Stein -- Vice President, Chief Medical Officer Ian Meredith -- Executive Vice President and Global Chief ... illegal pete's Jul 27, 2023 · MARLBOROUGH, Mass., July 27, 2023 /PRNewswire/ -- Boston Scientific Corporation (NYSE: BSX) generated net sales of $3.599 billion during the second quarter of 2023, growing 11.0 percent on a reported basis, 12.0 percent on an operational 1 basis and 11.6 percent on an organic 2 basis, all compared to the prior Dec 11, 2022 · MARLBOROUGH, Mass., Dec. 11, 2022 /PRNewswire/ -- Boston Scientific Corporation (NYSE: BSX) and Acotec Scientific Holdings Limited ("Acotec" and 6669.HK) announced today that Boston Scientific will make a partial offer to acquire a majority stake, up to a maximum of 65%, of shares of Acotec, a Chinese medical technology company that offers solutions designed for a variety of interventional ... Boston Scientific Corporation (NYSE:BSX) shares, rose in value on Friday, 07/28/23, with the stock price down by -1.80% to the previous day’s close as strong demand from buyers drove the stock to $51.69. Actively observing the price movement in the last trading, the stock closed the session at $52.64, falling within a range of $51.16 and $53.11.Boston Scientific Corporation (NYSE:NYSE:BSX) Q4 2022 Results Conference Call February 1, 2023 8:00 AM ETCompany ParticipantsLauren Tengler - Vice President, Investor RelationsMike Mahoney...Symbol. Price. %Change. BSX. 53.50. -0.87%. Webull offers kinds of Boston Scientific Corporation stock information, including NYSE:BSX real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, BSX stock news, and many more online research tools to help you make informed decisions.Sep 11, 2023 · The public float for BSX is 1.46B and currently, short sellers hold a 0.60% of that float. On September 11, 2023, BSX’s average trading volume was 7.14M shares. BSX) stock’s latest price update. Boston Scientific Corporation (NYSE: BSX) has seen a decline in its stock price by -0.04 in relation to its previous close of 53.89. MARLBOROUGH, Mass., Jan. 21, 2021 /PRNewswire/ -- Boston Scientific (NYSE: BSX) today announced that it has entered into a definitive agreement to acquire Preventice Solutions, Inc., a privately-held company which offers a full portfolio of mobile cardiac health solutions and services, ranging from ambulatory cardiac monitors – including short and long-term Holter monitors – to cardiac ... bingo card template Nisa Investment Advisors LLC boosted its position in shares of Boston Scientific Co. (NYSE:BSX - Free Report) by 3.9% in the first quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 334,482 shares of the medical equipmenT2 Biosystems, Inc. Common Stock. $0.56 +0.1067 +23.54%. Investors may trade in the Pre-Market (4:00-9:30 a.m. ET) and the After Hours Market (4:00-8:00 p.m. ET). Participation from Market Makers ...Boston Scientific Corp. BSX (U.S.: NYSE) Overview News Boston Scientific Corp. No significant news for in the past two years. Key Stock Data P/E Ratio (TTM) 90.55 ( 09/08/23) EPS (TTM)... Boston Scientific's estimated fair value is US$41.64 based on 2 Stage Free Cash Flow to Equity. Boston Scientific's US$51.11 share price signals that it might be 23% overvalued. The US$53.11 ...The latest price target for . Boston Scientific (NYSE: BSX) was reported by Mizuho on Monday, August 28, 2023.The analyst firm set a price target for 56.00 expecting BSX to rise to within 12 ... flood light with camera Aug 30, 2023 · Korea Investment CORP lowered its position in shares of Boston Scientific Co. ( NYSE:BSX – Free Report) by 12.1% during the 1st quarter, according to the company in its most recent filing with ... Home BSX • NYSE Boston Scientific Corporation Follow Share $53.87 After Hours: $53.92 (0.093%) +0.050 Closed: Sep 8, 5:03:29 PM GMT-4 · USD · NYSE · Disclaimer search Compare to Medtronic...Boston Scientific Corporation BSXNYSE BSXNYSE See on Supercharts Overview News Ideas Financials Technicals Forecast BSX chart Today 0.06% Week −1.23% 1 month 7.72% 6 months 14.51% Year to date 15.94% 1 year 33.69% 5 years 51.12% All time 1168.00% Key stats Market capitalization 78.863B USD Dividends yield (FY) — Price to earnings Ratio (TTM) 90.54 san diego mesa college summer 2023 Boston Scientific (NYSE:BSX) announced today that it completed the nearly $1.1 billion acquisition of the global surgical business of Lumenis. Marlborough, Massachusetts–based Boston Scientific ...According to the issued ratings of 16 analysts in the last year, the consensus rating for Boston Scientific stock is Buy based on the current 1 hold rating, 14 buy ratings and 1 strong buy rating for BSX. The average twelve-month price prediction for Boston Scientific is $58.50 with a high price target of $64.00 and a low price target of $50.00.Home BSX • NYSE Boston Scientific Corporation Follow Share $53.87 After Hours: $53.92 (0.093%) +0.050 Closed: Sep 8, 5:03:29 PM GMT-4 · USD · NYSE · Disclaimer search Compare to Medtronic...Boston Scientific Corporation (NYSE:BSX)’s traded shares stood at 8.08 million during the last session, with the company’s beta value hitting 0.78. At the close of trading, the stock’s price was $53.94, to imply a decrease of -0.61% or -$0.33 in intraday trading. The BSX share’s 52-week high hlpusd Jul 28, 2023 · In May Boston Scientific Corporation (NYSE:BSX) cancelled its plan to buy a majority stake in the publicly listed Korean medical device maker M.I.Tech for $230 million amid regulatory concerns. 8. Jun 11, 2019 · MARLBOROUGH, Mass., June 11, 2019 /PRNewswire/ -- Boston Scientific Corporation (NYSE: BSX) today announced the close of its acquisition of Vertiflex, Inc., a privately-held company that developed and commercialized the Superion ® Indirect Decompression System, a minimally-invasive device used to improve physical function and reduce pain in patients with lumbar spinal stenosis (LSS) – the ... β BSX. 0.81. Expected rate of return on Boston Scientific Corp. common stock 3. E ( RBSX) 11.79%. 1 Unweighted average of bid yields on all outstanding fixed-coupon U.S. Treasury bonds neither due or callable in less than 10 years (risk-free rate of return proxy). 2 See details ».Aug 15, 2022 · MARLBOROUGH, Mass., Aug. 15, 2022 /PRNewswire/ -- Boston Scientific Corporation (NYSE: BSX) today announced the acquisition of Obsidio, Inc., a privately-held company that has developed the Gel ... During the last session, Boston Scientific Corporation (NYSE:BSX)’s traded shares were 4.42 million, with the beta value of the company hitting 0.78. At the end of the trading day, the stock’s price was $53.87, reflecting an intraday loss of -0.04% or -$0.02.Boston Scientific (NYSE: BSX) and EndoChoice Holdings, Inc. (NYSE: GI) today announced the companies have entered into a definitive agreement under which Boston Scientific has agreed to acquire EndoChoice. Upon completion of. 2016-09-27: EX-99.1: BOSTON SCIENTIFIC TO ACQUIRE ENDOCHOICE Acquisition Will Expand Endoscopy Gastroenterology PortfolioFind real-time BSX - Boston Scientific Corp stock quotes, company profile, news and forecasts from CNN Business.Bleakley Financial Group LLC raised its holdings in Boston Scientific Co. (NYSE:BSX – Free Report) by 3.0% in the first quarter, according to the company in its most recent Form 13F filing with ...Jul 27, 2023 · Boston Scientific Corporation (NYSE:NYSE:BSX) Q2 2023 Earnings Conference Call July 27, 2023 7:30 AM ETCompany ParticipantsLauren Tengler - VP, IRMike Mahoney - Chairman & CEODan... The trading price of Boston Scientific Corporation (NYSE:BSX) floating lower at last check on Tuesday, September 05, closing at $53.44, -0.34% lower than its previous close. Traders who pay close attention to intraday price movement should know that it has been fluctuating between $53.34 and $54.26. The company’s P/E ratio in the trailing 12 ...February 2, 2023 at 3:58 PM · 21 min read. Boston Scientific Corporation (NYSE: BSX) Q4 2022 Earnings Call Transcript February 1, 2023. Operator: Good morning, and welcome to the Boston ... stlcc NYSE: BSX Show Full Chart Market Closed Sep 7, 2023 7:00 PM EDT | Currency in USD Overview Key Ratios Trading Information Last Close 53.89 Sector Healthcare Industry Medical Devices Investment...The latest price target for . Boston Scientific (NYSE: BSX) was reported by Mizuho on Monday, August 28, 2023.The analyst firm set a price target for 56.00 expecting BSX to rise to within 12 ... Nov 30, 2022 · The Boston-area medical device maker (NYSE: BSX) is set to buy Apollo Endosurgery Inc. (Nasdaq: APEN) at $10 a share, about a 60% premium over where it had been trading over the past week. For example, the Boston Scientific Corporation ( NYSE:BSX) share price is 51% higher than it was five years ago, which is more than the market average. It's also good to see a healthy gain of 32% ...Aug 21, 2023 · Boston Scientific Co. has a 52 week low of $37.74 and a 52 week high of $54.74. Boston Scientific ( NYSE:BSX – Get Free Report) last released its earnings results on Thursday, July 27th. The ... fairleigh dickinson location Symbol. Price. %Change. BSX. 53.50. -0.87%. Webull offers kinds of Boston Scientific Corporation stock information, including NYSE:BSX real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, BSX stock news, and many more online research tools to help you make informed decisions. Jun 5, 2023 · For example, the Boston Scientific Corporation ( NYSE:BSX) share price is 51% higher than it was five years ago, which is more than the market average. It's also good to see a healthy gain of 32% ... Jul 28, 2023 · In May Boston Scientific Corporation (NYSE:BSX) cancelled its plan to buy a majority stake in the publicly listed Korean medical device maker M.I.Tech for $230 million amid regulatory concerns. 8. MARLBOROUGH, Mass., Jan. 21, 2021 /PRNewswire/ -- Boston Scientific (NYSE: BSX) today announced that it has entered into a definitive agreement to acquire Preventice Solutions, Inc., a privately ...Jun 5, 2023 · For example, the Boston Scientific Corporation ( NYSE:BSX) share price is 51% higher than it was five years ago, which is more than the market average. It's also good to see a healthy gain of 32% ... vh1 activate Jun 15, 2022 · MARLBOROUGH, Mass., June 15, 2022 /PRNewswire/ -- Boston Scientific Corporation (NYSE: BSX) today announced that it has entered into a definitive agreement with Synergy Innovation Co., Ltd, to purchase its majority stake (approximately 64 percent) of M.I.Tech Co., Ltd, ("M.I.Tech") a publicly traded Korean manufacturer and distributor of medical devices for endoscopic and urologic procedures. Sep 12, 2023 · See the latest Boston Scientific Corp stock price (NYSE:BSX), related news, valuation, dividends and more to help you make your investing decisions. During the last session, Boston Scientific Corporation (NYSE:BSX)’s traded shares were 4.42 million, with the beta value of the company hitting 0.78. At the end of the trading day, the stock’s price was $53.87, reflecting an intraday loss of -0.04% or -$0.02.BSX U.S.: NYSE Boston Scientific Corp. Watch list Open Last Updated: Sep 7, 2023 2:13 p.m. EDT Real time quote $ 54.19 0.33 0.61% Previous Close $53.86 Advanced Charting Volume: 4.29M 65 Day... Boston Scientific's estimated fair value is US$41.64 based on 2 Stage Free Cash Flow to Equity. Boston Scientific's US$51.11 share price signals that it might be 23% overvalued. The US$53.11 ...Boston Scientific (NYSE:BSX) announced today that it completed the nearly $1.1 billion acquisition of the global surgical business of Lumenis. Marlborough, Massachusetts–based Boston Scientific ...Jan 25, 2006 Boston Scientific and Guidant Announce Signing of Merger Agreement Valued at $27 Billion. Natick, MA and Indianapolis, IN - Boston Scientific Corporation (NYSE: BSX) and Guidant Corporation (NYSE: GDT) today announced that the Board of Directors of Guidant has unanimously approved and entered into the merger agreement provided to Guidant by Boston Scientific on January 17, 2006. MARLBOROUGH, Mass., Jan. 21, 2021 /PRNewswire/ -- Boston Scientific (NYSE: BSX) today announced that it has entered into a definitive agreement to acquire Preventice Solutions, Inc., a privately-held company which offers a full portfolio of mobile cardiac health solutions and services, ranging from ambulatory cardiac monitors – including short and long-term Holter monitors – to cardiac ... dtw to orlando Aug 28, 2023 · Boston Scientific Corporation (NYSE:BSX)’s beta value is holding at 0.78, while the average true range (ATR) indicator is currently reading 0.83. Considering analysts have assigned the stock a price target range of $55.00-$68.00 as the low and high respectively, we find the trailing 12-month average consensus price target to be $60.50. The trading price of Boston Scientific Corporation (NYSE:BSX) floating lower at last check on Tuesday, September 05, closing at $53.44, -0.34% lower than its previous close. Traders who pay close attention to intraday price movement should know that it has been fluctuating between $53.34 and $54.26. The company’s P/E ratio in the trailing 12 ...Nisa Investment Advisors LLC boosted its position in shares of Boston Scientific Co. (NYSE:BSX - Free Report) by 3.9% in the first quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 334,482 shares of the medical equipmenBoston Scientific (NYSE:BSX) announced today that it agreed with Synergy Innovation to purchase its majority stake in M.I. Tech.. Marlborough, Massachusetts-based Boston Scientific will acquire a ...Boston Scientific Corporation (BSX) Stock Price, News, Quote & History - Yahoo Finance Boston Scientific Corporation (BSX) NYSE - Nasdaq Real Time Price. Currency in USD Follow 2W 10W 9M... sayfie review MARLBOROUGH, Mass., Sept. 6, 2023 /PRNewswire/ -- Boston Scientific Corporation (NYSE: BSX) today announced it has received U.S. Food and Drug Administration approval for the latest-generation ...Sep 15, 2023 · Nexus Investment Management ULC raised its holdings in shares of Boston Scientific Co. (NYSE:BSX – Free Report) by 0.8% in the 2nd quarter, according to its most recent filing with the ... Sep 12, 2023 · Boston Scientific Corporation (NYSE:BSX) entered into a definitive merger agreement to acquire Apollo Endosurgery, Inc. (NasdaqGM:APEN) for approximately $440 million. Nov 30 Boston Scientific Corporation Announces the First Results from the ACURATE neo2 Post Market Clinical Follow-up (PMCF) Study Jul 27, 2023 · Boston Scientific Corporation (NYSE:NYSE:BSX) Q2 2023 Earnings Conference Call July 27, 2023 7:30 AM ETCompany ParticipantsLauren Tengler - VP, IRMike Mahoney - Chairman & CEODan... MARLBOROUGH, Mass., Feb. 15, 2022 /PRNewswire/ -- Boston Scientific Corporation (NYSE: BSX) today announced the close of its acquisition of Baylis Medical Company Inc., a company that offers ...